Tumor–stromal metabolic crosstalk in pancreatic cancer
Trends in Cell Biology · 2025-12 · 35 (12) · 1068-1083
DOI: 10.1016/j.tcb.2025.04.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Cell Biology, 2025-12. Verfasst von Ravi Thakur und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology Science, University of Oklahoma College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Tumor Microenvironment, Stromal Cells, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, National Institutes of Health National Cancer Institute.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a dire prognosis. Standard-of-care chemotherapy regimens offer marginal survival benefit and carry risk of severe toxicity, while immunotherapy approaches have uniformly failed in clinical trials. Extensive desmoplasia in the PDAC tumor microenvironment (TME) disrupts blood flow to and from the tumor, thereby creating a nutrient-depleted, hypoxic, and acidic milieu that suppresses the function of antitumor immune cells and imparts chemotherapy resistance. Additionally, recent seminal studies have demonstrated crucial roles for metabolic crosstalk - the exchange of metabolites between PDAC cells and stromal cell populations in the TME - in establishing and maintaining core malignant behaviors of PDAC: tumor growth, metastasis, immune evasion, and therapy resistance. In this review, we provide a conceptual overview of metabolic crosstalk and how it evolves under various selection pressures in the TME, analyze the landscape of proposed tumorigenic metabolic crosstalk pathways, and highlight potentially druggable nodes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology Science, University of Oklahoma College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
- Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA.
- Department of Oncology Science, University of Oklahoma College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Eppley Institute for Research in Cancer and Allied Diseases, University…
Förderung
- NCI NIH HHS
- National Institutes of Health
- National Institutes of Health National Cancer Institute
Zitieren
APA
Thakur, R., Mullen, N. J., Mehla, K., & Singh, P. K. (2025). Tumor–stromal metabolic crosstalk in pancreatic cancer. Trends in Cell Biology, 35(12), 1068-1083. https://doi.org/10.1016/j.tcb.2025.04.007
Vancouver
Thakur R, Mullen NJ, Mehla K, Singh PK. Tumor–stromal metabolic crosstalk in pancreatic cancer. Trends in Cell Biology. 2025;35(12):1068-1083. doi:10.1016/j.tcb.2025.04.007
BibTeX
@article{Thakur2025,
author = {Thakur, Ravi and Mullen, Nicholas J and Mehla, Kamiya and Singh, Pankaj K},
title = {Tumor–stromal metabolic crosstalk in pancreatic cancer},
journal = {Trends in Cell Biology},
year = {2025},
volume = {35},
number = {12},
pages = {1068--1083},
doi = {10.1016/j.tcb.2025.04.007}
}
EUVIMED